Custodio, LuisaVizetto-Duarte, CatarinaCebeci, FatmaOzcelik, BeraatSharopov, FarukhGurer, Eda SonmezKumar, Manoj2024-10-042024-10-0420232666-3066https://doi.org/10.1002/efd2.57http://hdl.handle.net/20.500.12403/3513Attention deficit hyperactivity disorder (ADHD) is among the most common neurodevelopmental disorders characterized by motor hyperactivity, attention deficit, distraction, impulsive behavior, and relationship difficulties. It affects children, and thus over the years, there has been growing attention on the use of natural product formulations and their naturally-occurring bioactive for overcoming the problem of ADHD. Concerning this issue, this review aims to discuss the ADHD treatment potential of natural products/formulations in vitro, in vivo as well as in clinical trials. To gather the most relevant data regarding bioactive compounds with potential therapeutic effects in the management of ADHD, the following databases were searched: PubMed/MedLine, ScienceDirect, and Google Scholar for articles in English. Various medicinal plants and their isolated biomolecules have been evaluated in vitro, in vivo, and in clinical trials for their ability to treat ADHD. Most of the analyzed research results showed an improvement of ADHD signs and symptoms in in vivo models, but the molecular mechanisms of action of the bioactive compounds are unclear and incompletely elucidated. Further studies are needed to determine the bioactive compound responsible for health-promoting effects in ADHD. In addition, clinical studies should be performed over longer periods with more participants.eninfo:eu-repo/semantics/openAccessADHDclinical studiesnatural productspharmacotherapeutic managementpreclinical studiesReview Article4110.1002/efd2.572-s2.0-85147213223N/AWOS:001191742300001Q2